Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

J Antimicrob Chemother. 2020 Oct 1;75(10):3084-3086. doi: 10.1093/jac/dkaa253.

Felix Stader^{1

2}, Saye Khoo³, Marcel Stoeckle^{1

2}, David Back³, Hans H Hirsch^{1

4}, Manuel Battegay^{1

2}, Catia Marzolini^{1

3}

¹ Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland.
² University of Basel, Basel, Switzerland.
³ Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
⁴ Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.

No abstract available

Publication types